Covid-19 in Parkinson's Disease treated by drugs or brain stimulation
Open Access
- 1 August 2021
- journal article
- Published by Elsevier BV in Neurología
Abstract
No abstract availableKeywords
Funding Information
- Shahid Beheshti University of Medical Sciences
This publication has 10 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) among Patients at a Movement Disorders CenterGeriatrics, 2020
- Exercise for Older Adults Improves the Quality of Life in Parkinson’s Disease and Potentially Enhances the Immune Response to COVID-19Brain Sciences, 2020
- COVID-19 in Parkinson's disease: Report on prevalence and outcomeParkinsonism & Related Disorders, 2020
- Predictors of COVID-19 outcome in Parkinson's diseaseParkinsonism & Related Disorders, 2020
- Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross‐Sectional Survey of 568 Spanish PatientsMovement Disorders, 2020
- COVID‐19 in Parkinson’s Disease Patients Living in Lombardy, ItalyMovement Disorders, 2020
- COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient CareJournal of Movement Disorders, 2020
- Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID‐19) PandemicMovement Disorders, 2020
- The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging OpportunitiesJournal of Parkinson's Disease, 2020
- Parkinson diseaseNature Reviews Disease Primers, 2017